Ultrasound-guided womb lining biopsy for postmenopausal bleeding
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new way to take a small sample of the womb lining (biopsy) using a thin, flexible tube guided by ultrasound. The goal is to see if ultrasound guidance makes the biopsy more accurate and comfortable in people with post-menopausal bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vaginal bleeding that started again at least one year after your last period (or 6 months after starting continuous combined HRT).
- You are age 18 or older.
- An ultrasound shows your womb lining is 5mm or thicker and appears smooth with clear edges.
- You do not have any known polyps or fibroids inside your womb.
- You can have a vaginal examination and are able to give written consent.
- You have no history of endometrial (womb lining) cancer, hyperplasia (pre-cancer), or cervical cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This trial tests a new type of vaginal speculum designed to make endometrial biopsies (a procedure to take a small sample of the lining of the uterus) more comfortable and effective. If you have had this biopsy before at the Minnesota Oncology Clinic, you may be eligible to help evaluate this new tool.
This study looks at how well an ultrasound-guided needle biopsy (Tru-Cut) can safely collect tissue samples from pelvic masses. It may help doctors confirm diagnoses and guide treatment by improving how biopsies are done in real-world care.
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study tests a new device that collects a sample from the vagina to see if it can find endometrial (uterine) or ovarian cancers. If you are seeing a gynecologist and can tolerate a speculum or tampon, you may be able to help.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.